DAX24.181 -0,2%Est505.605 +1,0%MSCI World4.303 +0,6%Top 10 Crypto15,56 +1,1%Nas22.658 +0,6%Bitcoin95.602 -2,0%Euro1,1639 +0,2%Öl62,25 -0,1%Gold4.206 +1,5%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 DroneShield A2DMAA RENK RENK73 D-Wave Quantum A3DSV9 Plug Power A1JA81 European Lithium A2AR9A BASF BASF11 Siemens Energy ENER6Y Tesla A1CX3T BYD A0M4W9 Novo Nordisk A3EU6F Amazon 906866 NEL ASA A0B733 LVMH Moet Hennessy Louis Vuitton 853292
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Hoffnung auf US-Zinssenkung: Dow knapp im Plus -- DAX schließt schwächer -- China lastet auf Rheinmetall, RENK und HENSOLDT -- Goldpreisrekord, NEL, BASF, D-Wave, DroneShield, AMD im Fokus
Top News
Webinar: KI für Anleger - ein Power-Workshop mit Augenzwinkern Richtung Börse Webinar: KI für Anleger - ein Power-Workshop mit Augenzwinkern Richtung Börse
Krypto-Unternehmen Tether plant Milliarden-Kapitalerhöhung Krypto-Unternehmen Tether plant Milliarden-Kapitalerhöhung
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Bitcoin korrigiert - könnte jetzt ein interessanter Moment zum Investieren sein?

Natural Field Drives Breakthroughs in Co-loading Liposome Technology, Accelerating Upgrading of Raw Materials for Cardiovascular and Gut Health

13.10.25 17:00 Uhr

XIAN, China, Oct. 13, 2025 /PRNewswire/ -- Natural Field has achieved new continuous research breakthroughs in co-loading liposome technology, with remarkable progress particularly in the development of co-loading Coenzyme Q10 (CoQ10) liposome and co-loading curcumin liposome raw materials. This technology demonstrates strong potential in enhancing the bioavailability, stability, and synergistic effects of active ingredients, opening up new pathways for health support.

During this R&D process, Natural Field conducted in-depth exploration into the mechanisms of action and efficacy of co-loading CoQ10 liposomes and co-loading curcumin liposomes in areas such as cardiovascular function and gut health. Experimental data shows that the bioabsorption rate of these two co-loading liposomes is 2-10 times higher than that of traditional raw materials. These preliminary data indicate that NFLipo® has more competitive performance in cardiovascular protection, antioxidant, anti-inflammatory, and intestinal barrier regulation.

This technological breakthrough brings the following advantages:

  • Higher Bioavailability: Through structural optimization of co-loading liposomes, multiple functional ingredients can be synergistically packaged and stably delivered to target sites more efficiently.

  • Improved Stability: Ordinary liposomes still rely on cellular uptake after extracellular release, which is easily limited by P-glycoprotein (P-gp) efflux, resulting in insufficient intracellular entry efficiency. The new co-loading liposome technology can not only effectively bypass this efflux pathway but also inhibit its activity, thereby significantly improving the bioavailability of ingredients and enhancing their stability during storage and in-vivo transportation.

  • Synergistic Efficacy Potential: The combination of rare ginsenosides with CoQ10 and curcumin not only enhances membrane stability but also co-loads more active ingredients. For example, it meets the synergistic effects of antioxidant support and anti-aging skin care, expanding the functional dimensions of products.

  • Enhanced Customized Development Capabilities: Natural Field has launched a "one-stop liposome service" model, providing customers with personalized customization solutions covering formula design, process optimization, quality control, and large-scale production.

    • As a 20-year supplier in the nutritional health raw material sector, Natural Field has always emphasized both technological innovation and standardized compliance. Currently, its official website clearly lists "co-loading liposomes" as a key product category, and the company has repeatedly highlighted the technology's patent potential and application scenarios in exhibition promotions.

    To promote industry exchanges and application implementation, Natural Field will participate in the SupplySide Global Exhibition in the U.S. in October 2025, Booth No.6247. At the exhibition, it will showcase its latest co-loading liposome platform and sample products, and conduct in-depth dialogues with global nutritional health raw material suppliers, health supplement manufacturers, and research institutions to explore cooperation opportunities for liposomes in nutritional support and functional raw materials.

    Through this technological showcase, Natural Field aims to further establish its leading position in the liposome and co-loaded liposome technology field in the international market, provide customers with more efficient, safer, and more differentiated raw material solutions, and drive the entire nutritional health industry toward a higher technological threshold and value chain level.

    Co-loaded Liposomes Show Enhanced Cardiovascular Support — Both CoQ10 and Curcumin liposomes demonstrated superior improvement compared to their conventional forms under experimental conditions.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/natural-field-drives-breakthroughs-in-co-loading-liposome-technology-accelerating-upgrading-of-raw-materials-for-cardiovascular-and-gut-health-302581739.html

    SOURCE Natural Field